FTC Warns Drugmakers, Middlemen Over Rebates
The Federal Trade Commission issued a policy statement warning drug companies and pharmacy benefits managers that enforcers are looking to go after rebates and other pricing schemes the agency said block...To view the full article, register now.
Already a subscriber? Click here to view full article